FORM 8-K

Company

TScan Therapeutics, Inc.

Filed

November 21, 2024

Period of Report

November 15, 2024

Accession Number

0000950142-24-002817

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →